MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PHIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Phio Pharmaceuticals (PHIO) Ownership - Who owns Phio Pharmaceuticals?

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
411 Swedeland Road
Phone
+1 610 947-0251
Employees
6
Web
https://www.phiopharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.97M
P/E Ratio
0.01
Total Cash
17.03M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.24
Dividend Yield
N/A
Total Cash/Share
1.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PHIO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PHIO
A.I. Advisor
published General Information

General Information

a developer of RNAi-based medical technologies and therapies

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
411 Swedeland Road
Phone
+1 610 947-0251
Employees
6
Web
https://www.phiopharma.com